Prognostic factors for patients with advanced non-small cell lung cancer treated with gemcitabine-platinum as first-line therapy in an observational setting in China

BACKGROUND: This study examined the prognostic factors associated with survival in advanced non-small cell lung cancer (NSCLC) patients receiving gemcitabine-platinum regimens as first-line therapy in real-world clinical settings in China. METHODS: Data was analyzed from a multinational, prospective...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Ye, Wenyu, Yang, Yicheng, Wang, Jin, Kadziola, Zbigniew, Rajan, Narayan, Qin, Shukui
Format: Artigo
Language:Inglês
Published: BlackWell Publishing Ltd 2014
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704354/
https://ncbi.nlm.nih.gov/pubmed/26767019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12095
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items